CN110437268B - Potassium ion probe and preparation method and application thereof - Google Patents
Potassium ion probe and preparation method and application thereof Download PDFInfo
- Publication number
- CN110437268B CN110437268B CN201910832447.8A CN201910832447A CN110437268B CN 110437268 B CN110437268 B CN 110437268B CN 201910832447 A CN201910832447 A CN 201910832447A CN 110437268 B CN110437268 B CN 110437268B
- Authority
- CN
- China
- Prior art keywords
- probe
- potassium ion
- oxygen
- polyethylene glycol
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 124
- 229910001414 potassium ion Inorganic materials 0.000 title claims abstract description 109
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 238000002360 preparation method Methods 0.000 title claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 98
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 98
- 239000001301 oxygen Substances 0.000 claims abstract description 98
- 239000000126 substance Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 41
- 239000002202 Polyethylene glycol Substances 0.000 claims description 26
- 229920001223 polyethylene glycol Polymers 0.000 claims description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 238000001514 detection method Methods 0.000 claims description 20
- 238000006116 polymerization reaction Methods 0.000 claims description 15
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000010453 quartz Substances 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 12
- 239000000017 hydrogel Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 10
- 239000003999 initiator Substances 0.000 claims description 9
- 239000007822 coupling agent Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical group CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 230000000379 polymerizing effect Effects 0.000 claims description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 2
- 230000001588 bifunctional effect Effects 0.000 claims description 2
- 239000007810 chemical reaction solvent Substances 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims 1
- 230000004044 response Effects 0.000 abstract description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 6
- 239000010408 film Substances 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 239000011591 potassium Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940126214 compound 3 Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007954 hypoxia Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 239000004005 microsphere Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000835 electrochemical detection Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- MFFMQGGZCLEMCI-UHFFFAOYSA-N 2,4-dimethyl-1h-pyrrole Chemical compound CC1=CNC(C)=C1 MFFMQGGZCLEMCI-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PAPNRQCYSFBWDI-UHFFFAOYSA-N DMP Natural products CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 description 2
- 108091081406 G-quadruplex Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000002682 Hyperkalemia Diseases 0.000 description 2
- 208000019025 Hypokalemia Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 230000004098 cellular respiration Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000006241 metabolic reaction Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000002082 metal nanoparticle Substances 0.000 description 2
- 230000006686 mitochondrial oxygen consumption Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 208000024896 potassium deficiency disease Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006536 aerobic glycolysis Effects 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 230000008695 pulmonary vasoconstriction Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1048—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1055—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1074—Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
- C09K2211/1077—Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms with oxygen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The potassium ion probe provided by the invention has high selectivity on potassium ions, can emit green fluorescence and can detect K+And the potassium ion probe contains hydroxyl, so that the potassium ion probe can be grafted with a carrier more easily, and can be grafted on the carrier together with other types of probes to realize multiple responses of the same sensing film. The invention also provides a potassium ion and dissolved oxygen dual-functional sensing film, which comprises a carrier, and a potassium ion probe, an oxygen probe and a reference probe which are fixed on the surface of the carrier in a chemical bonding mode.
Description
Technical Field
The invention relates to the technical field of biological materials, in particular to a potassium ion probe and a preparation method and application thereof, and particularly relates to a potassium ion probe and a preparation method thereof, a potassium ion and dissolved oxygen dual-functional sensing film and a preparation method thereof.
Background
Potassium ion (K)+) Is one of the most abundant metal ions in mammalian cells, and accounts for about 0.35% of human body dry weight. It plays an extremely important role in numerous physiological activities,including heart beat, muscle contraction, nerve signal conduction, renal excretion, etc. K+Not only participate in maintaining the osmotic pressure and electrolyte balance inside and outside cells and regulating blood pressure, but also participate in regulating the transduction of biochemical signals of the whole nervous system. K in mammalian cell cytoplasm+The ion concentration was about 130-180mM, while the extracellular concentration was 3.5-5.0 mM. Normal serum potassium levels are maintained at 3.5-5.5mM and when ingested in excess, excess K is normally cleared by renal excretion+. When the concentration of potassium in blood is higher than 5.5mM, the hyperkalemia is generally called as hyperkalemia; at low to high concentrations (5.5-6.0mM) or at medium to high concentrations (6.1-6.9mM), nausea, fatigue, muscle weakness and sometimes arrhythmias are often caused; when the blood potassium concentration is higher than 7.0mM, cardiac arrest and even death is usually caused. When the blood potassium concentration is below 3.5mM, it is collectively called hypokalemia. Symptoms clinically associated with hypokalemia include: weakness, paralysis, rigidity of limbs, intestinal obstruction, nausea, vomiting, etc. K+Abnormal concentrations are often an early sign of certain diseases, such as alcohol abuse, anorexia, bulimia, heart disease, diabetes, aids, cancer, and the like.
Therefore, finding a highly sensitive method that can specifically study, measure or monitor the intracellular and extracellular potassium ion concentrations in real time is of great significance to the development and screening of drugs related to pathological processes and diseases.
Oxygen is one of the very important elements or parameters in the fields of environmental protection, engineering, marine production, industry and agriculture, especially in the biological field, oxygen is one of the important raw materials for cell metabolism, and is the source of energy for maintaining life activities. With the development of scientific research, the influence of oxygen concentration on cells is gradually recognized. Although oxygen is essential for the metabolism of cells, an increase in oxygen concentration also causes some toxicity. In high oxygen environments, aerobic and microaerophilic cells or tissues may initiate their own protective mechanisms to cope with the current abnormal environment. Superoxide (O) known as reactive oxygen species2 -) And hydrogen peroxide (H)2O2) Will become a by-product of cell metabolismIntracellular accumulation, because these reactive oxygen species are more reactive than normal oxygen molecules, eventually oxidize intracellular macromolecules and thus cause apoptosis. Similarly, if the intracellular oxygen concentration is below normal, it will result in aerobic and microaerophilic cell or tissue ischemic injury and even cell death. Hypoxia of cells can also lead to a variety of diseases such as chronic vascular diseases, neurological disorders, pulmonary diseases and even cancer.
Therefore, the ability to accurately and precisely measure the oxygen content in cells is of great importance for understanding the biological viability of cells, studying the pathology of various diseases, and diagnosing and treating cancer.
It is well known that cellular respiration is a series of metabolic reactions and processes occurring in biological organs and tissues, whereby cells acquire energy such as Adenosine Triphosphate (ATP) and discharge waste materials such as carbon dioxide. Although the detection of intracellular oxygen levels has been reported, the detection of extracellular oxygen levels is still not negligible and many biological metabolic processes are still investigated by measuring extracellular oxygen levels. During cellular metabolic reactions, mitochondria are critical organelles that support aerobic respiration and gain ATP. However, cellular respiration is not dependent on mitochondria, and mitochondria are not required for yet another type of respiration, known as non-mitochondrial oxygen consumption. Studying non-mitochondrial oxygen consumption characteristics requires measuring extracellular oxygen consumption. Therefore, the ability to accurately and precisely measure the oxygen consumption of cells during respiration is very important for evaluating aerobic glycolysis rate, oxidative phosphorylation, and high-throughput drug screening, among others.
Opening and closing of potassium ion channel and K+Both influx and efflux at the cell membrane are affected by the concentration of Dissolved Oxygen (DO) in the body. For example, hypoxia causes myocardial K+Resulting in myocardial dysfunction. In addition, acute systemic hypoxia can cause arterial K+The concentration increases, causing peripheral circulation vasodilation. Cerebral dysfunction and pulmonary vasoconstriction also associated with hypoxia-induced K+The imbalance is related. Thus, K is measured simultaneously+Concentration ofAnd DO concentration are very important.
CN106929008B discloses a potassium ion fluorescent probe and a preparation method and application thereof, the potassium ion fluorescent probe of the invention takes phenyl aza-18-crown-6-amine as an identification group and a hemicyanine dye group as a fluorescent group, has the advantages of sensitivity to the environment, good water solubility, high detection accuracy, quick response to the change of potassium ion concentration and the like, is a colorimetric and instant ratio type potassium ion detection probe, can be prepared into detection test paper, realizes quick detection of high and low potassium ion content according to the color change of the test paper, is expected to detect the potassium ion concentration in the aspects of traditional Chinese medicine injection, red wine, human urine or blood and the like, and has wide application prospect.
CN105241845B preparation and application of a single particle SPR probe for real-time monitoring of G-quadruplex formation. Based on good biocompatibility, large specific surface area and high SPR sensitivity of the noble metal nanoparticles, telomeres capable of being specifically combined with potassium ions are adopted to carry out surface modification on the noble metal nanoparticles, and the single-particle biological probe capable of detecting the potassium ions with high sensitivity and monitoring the G-quadruplex formation process in real time is simply and conveniently constructed. The probe has the function of real-time detection, and has the advantages of high detection speed, high sensitivity, wide detection range and the like. In addition, the dissociation constant K for the formation of G-quartets can be obtained by data fitting analysisdAnd gibbs free energy Δ G, as well as two binding site morphologies during formation.
CN108333162A discloses a fluorescent oxygen probe, which comprises a polymer microsphere copolymerized with a reference probe compound and a fluorescent oxygen probe compound uniformly dispersed in the polymer microsphere copolymerized with the reference probe compound, and also provides an inventive method for preparing the fluorescent oxygen probe, preparing microspheres dispersed with a fluorescent oxygen probe compound by copolymerizing a reference probe compound with a polymerization monomer, wherein the microspheres can be used as a fluorescent oxygen probe, the fluorescent oxygen probe prepared by the invention has self-reference effect, avoids the problem that the fluorescent probe needs to be recalibrated when the detection equipment is replaced in the traditional fluorescent detection, and in addition, when the electrochemical detection device is used, the requirement on detection environment is not high, the electrochemical detection device can be used for detecting the concentration of dissolved oxygen in dynamic biological environments such as water bodies containing microorganisms, and the like, and the detection result error is less than or equal to 5 percent compared with that of the traditional electrochemical detection device.
As can be seen from the above-disclosed patents, sensors that measure the concentration of potassium ions alone or the concentration of oxygen alone have been well developed. However, no sensor capable of measuring the concentration of oxygen and potassium ions simultaneously and in real time exists at present.
Therefore, there is a need in the art to simultaneously and real-time measure oxygen and potassium ion concentrations.
Disclosure of Invention
In view of the shortcomings of the prior art, one of the objectives of the present invention is to provide a potassium ion probe, and more particularly, to provide a potassium ion probe for a potassium ion and dissolved oxygen dual-function sensing film. The potassium ion probe has high selectivity on potassium ions, emits green fluorescence and can detect K+And (4) concentration. And the potassium ion probe can be connected with the carrier through hydroxyl.
In order to achieve the purpose, the invention adopts the following technical scheme:
the present invention provides a potassium ion probe, wherein the potassium ion probe (KS-23) has the following structure:
the potassium ion probe provided by the invention has high selectivity on potassium ions, can emit green fluorescence, and can detect K+And the potassium ion probe contains hydroxyl, so that the potassium ion probe can be grafted with a carrier more easily, and can be grafted on the carrier together with other types of probes to realize multiple responses of the same sensing film.
The response mechanism of the potassium ion probe is as follows:
another object of the present invention is to provide a method for preparing the potassium ion probe according to the first object, the method comprising: the potassium ion probe is obtained by reacting a compound 3 with a compound 3', and the reaction formula is as follows:
preferably, the solvent for the reaction comprises any one or a combination of at least two of ethanol, toluene and benzene.
Preferably, a catalyst is added to the reaction, the catalyst comprising piperidine and/or pyridine.
Preferably, the reaction is carried out under reflux.
Preferably, the compound 3 is obtained by reacting the compound 2 with 2, 4-dimethylpyrrole, and has the following reaction formula:
preferably, the solvent for the reaction includes any one or a combination of at least two of tetrahydrofuran, dioxane, acetonitrile and dichloromethane.
Preferably, a catalyst is added to the reaction, the catalyst comprising trifluoroacetic acid and/or BF3·Et2O。
Preferably, a dehydrogenation agent is added in the reaction, and the dehydrogenation agent comprises 3-dichloro-5, 6-dicyan p-benzoquinone and/or tetrachloro p-quinone.
Preferably, an acid scavenger is added to the reaction, wherein the acid scavenger comprises triethylamine.
Preferably, the compound 2 is obtained by reacting the compound 1 with 2-bromoethanol, and the reaction formula is shown as formula III:
preferably, a catalyst is added to the reaction, the catalyst comprising potassium iodide.
Preferably, an acid-binding agent is added to the reaction, and the acid-binding agent comprises potassium carbonate.
Preferably, the solvent of the reaction comprises CH3Any one or at least two of CN, acetone and N, N-dimethylformamide.
The potassium ion and dissolved oxygen dual-function sensing film comprises a carrier, and a potassium ion probe (KS-23), an oxygen probe (OS) and a Reference Probe (RP) which are fixed on the surface of the carrier in a chemical bonding mode;
preferably, the oxygen probe (OS) has the following structure:
preferably, the Reference Probe (RP) has the following structure:
the potassium ion probe, the oxygen probe and the reference probe with specific structures are jointly bonded on the carrier, wherein the potassium ion probe responds to potassium ions and emits green fluorescence, the oxygen probe responds to dissolved oxygen and emits red fluorescence, and the reference probe does not respond to both the potassium ions and the dissolved oxygen and emits blue fluorescence. Therefore, the film has red, green and blue fluorescence, the three fluorescence colors are not interfered with each other, and the accurate simultaneous measurement of potassium ions and dissolved oxygen can be realized by using a fluorescence colorimetric method.
In addition, the three probes are fixed on the carrier in a chemical bonding mode, so that the sensing film is more stable.
In the present invention, the preparation method of the oxygen probe OS is described in the article: jianan Shi, Yifei Zhou, Jianpei Jiang, tinting Pan, Zhipeng Mei, Jianxing Wen, Cheng Yang, Zijin Wang, Yanqing Tian, European Polymer Journal, 112, 214-.
Reference probes of the present invention are synthesized by reference to the preparation methods described in the following papers or patents:
the patent: CN106947381A
The article: zhang, J.H.ZHou, H.Li, J.H.He, N.J.Li, Q.F.xu, D.Y.Chen, H.Li, J.M.Lu, The Effect of Random and Block polymerization with Pender carbide nanoparticles and nanoparticles Acceptors on Multilevel Memory, Chem Asian J.13(2018) 853-.
Preferably, the support is a quartz support modified by TMSPA, and the TMSPA has the following structure:
the fourth purpose of the present invention is to provide a method for preparing the potassium ion and dissolved oxygen dual-functional sensing thin film, which comprises the following steps:
(1') polymerizing polyethylene glycol methacrylate (PEGMA), methacrylic acid (MAA), polyethylene glycol dimethacrylate (PEGDMA), an oxygen probe and a reference probe on the surface of a carrier to obtain a carrier (F-OS-RP) covered with a hydrogel layer;
(2') grafting the potassium ion probe of one purpose on the surface of the carrier covered with the hydrogel layer to obtain the potassium ion and dissolved oxygen dual-function sensing film.
The method takes PEGMA as a hydrogel monomer and PEGDMA as a cross-linking agent to obtain stable hydrogel, an oxygen probe OS and a reference probe RP contain methacrylate ester bonds, MAA is added at the same time and can be polymerized with the used monomer, the monomer is polymerized and then integrated with a carrier to obtain a film (F-OS-RP) containing the oxygen probe, the reference probe and an active carboxyl, and then KS-23 is bonded on the carrier through the reaction of the active carboxyl and hydroxyl on KS-23, and the three probes are bonded with the carrier in a chemical bonding mode, so that the stability of the film is improved.
Preferably, the support surface contains double bonds.
Preferably, in step (1'), the initiator for the polymerization reaction comprises Azobisisobutyronitrile (AIBN).
Preferably, in step (1'), the solvent for the polymerization reaction includes N, N-Dimethylformamide (DMF).
Preferably, in step (1'), the support is a TMSPA-modified quartz support.
In a preferred embodiment of the present invention, the surface of the carrier is modified with double bond-containing and silane bond-containing TSMPA, so that the gel is stable on the surface of the carrier, and the stability of the film is further improved.
Preferably, in step (1'), the mass ratio of polyethylene glycol methacrylate, polyethylene glycol dimethacrylate, the oxygen probe, the reference probe, the initiator and the solvent is 500-1500:20-300:1-15:1-15:5-30:1000, preferably 800:50:5:5:10: 1000.
Preferably, in step (1'), the mass ratio of the methacrylic acid to the polyethylene glycol methacrylate is 10-1000: 1.
Preferably, in step (1'), the number average molecular weight of the polyethylene glycol methacrylate is 300-2000, preferably 500.
Preferably, in step (1'), the number average molecular weight of the polyethylene glycol dimethacrylate is 300-2000, preferably 750.
Preferably, in step (1'), the polymerization reaction is carried out under a nitrogen atmosphere.
Preferably, in step (1'), the polymerization temperature is 70-90 ℃, such as 72 ℃, 73 ℃, 75 ℃, 78 ℃, 80 ℃, 82 ℃, 85 ℃, 88 ℃, etc., preferably 80 ℃.
Preferably, in step (1'), the polymerization time is 0.8 to 1.5h, e.g., 0.9h, 1h, 1.2h, 1.3h, 1.4h, etc., preferably 1 h.
Preferably, step (1') comprises in particular: mixing polyethylene glycol methacrylate, methacrylic acid, polyethylene glycol dimethacrylate, an oxygen probe, a reference probe, an initiator and a solvent, taking the mixed solution to be arranged on the surface of a TMSPA modified quartz carrier, and polymerizing for 0.8-1.5h at the temperature of 70-90 ℃ to obtain the carrier covered with the hydrogel layer.
Preferably, in step (2'), a coupling agent and/or a catalyst is added.
Preferably, the coupling agent comprises 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride.
Preferably, the catalyst comprises 4-dimethylaminopyridine.
Preferably, in the step (2'), the mass ratio of the potassium ion probe, the coupling agent and the catalyst is 2:1000: 200.
Preferably, in step (2'), the reaction solvent for grafting comprises N, N-dimethylformamide.
Preferably, in step (2'), the reaction time for the grafting is 10 to 15h, such as 11h, 12h, 13h, 14h, etc., preferably 12 h.
Preferably, in step (2'), the reaction of grafting is carried out at room temperature.
Preferably, step (2') specifically comprises the steps of: and (3) placing the carrier covered with the hydrogel layer in a mixed solution of a potassium ion probe, a coupling agent and a catalyst, and carrying out grafting reaction for 10-15h at room temperature to obtain the potassium ion and dissolved oxygen dual-function sensing film.
The fifth purpose of the present invention is to provide an application of the three-purpose dual-function sensing film for potassium ions and dissolved oxygen in potassium ion detection and dissolved oxygen detection.
Compared with the prior art, the invention has the following beneficial effects:
(1) the potassium ion probe provided by the invention has high selectivity on potassium ions, can emit green fluorescence, and can detect K+The concentration and the hydroxyl contained in the potassium ion probe are easier to graft with a carrier, and the potassium ion probe and other types of probes are grafted on the carrier together, so that multiple responses of the same sensing film are realized;
(2) the potassium ion probe, the oxygen probe and the reference probe with specific structures are jointly bonded on the carrier, wherein the potassium ion probe responds to potassium ions and emits green fluorescence, the oxygen probe responds to dissolved oxygen and emits red fluorescence, and the reference probe does not respond to both the potassium ions and the dissolved oxygen and emits blue fluorescence. Therefore, the film has red, green and blue fluorescence, the three fluorescence colors are not interfered with each other, and the accurate simultaneous measurement of potassium ions and dissolved oxygen can be realized by using a fluorescence colorimetric method;
(3) the method takes PEGMA as a hydrogel monomer and PEGDMA as a cross-linking agent to obtain stable hydrogel, the oxygen probe OS and the reference probe RP contain methacrylate bonds and can be polymerized with the used monomer, the monomer is polymerized and then integrated with a carrier, MAA is added to enable KS-23 containing hydroxyl to be connected into a colloid, and the three probes are combined with the carrier in a chemical bonding mode, so that the stability of the film is improved.
Drawings
FIG. 1 is a schematic diagram of a method for preparing a potassium ion and dissolved oxygen dual-functional sensing film in example 1 of the present invention.
FIG. 2a is a graph showing the response of the reference probe to oxygen in test example 1.
FIG. 2b is a graph showing the response of the reference probe to potassium ions in test example 1.
FIG. 3a is a graph showing the response of the film to potassium ions under excitation at 405 nm in test example 1.
FIG. 3b is a graph showing the response of the film to oxygen under excitation at 405 nm for test example 1.
FIG. 4a is a graph showing the relationship between the oxygen concentration in test example 1 and the fluorescence ratio of the reference probe to the oxygen probe.
FIG. 4b is a graph showing the relationship between the concentration of potassium ions and the fluorescence ratio of potassium ion probe to reference probe in test example 1.
FIG. 5a is a graph comparing the effect of the film in test example 2 on the concentration of potassium and sodium ions on the fluorescence intensity.
FIG. 5b is a graph showing the comparison of the fluorescence intensity of the film in test example 2 for potassium ions and different metal ions,
Detailed Description
For the purpose of facilitating an understanding of the present invention, the present invention will now be described by way of examples. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
Synthesis example 1
This synthesis example provides a method for synthesizing a potassium ion probe KS-23, specifically as follows:
(1) synthesis of Compound 2: 4-hydroxybenzaldehyde (4.8g, 0.04mol), 2-bromoethanol (4.83g, 0.06mol), KI (3.32g, 0.02mol) and K2CO3(8.29g, 0.06mol) was added to a 250ml round bottom flask, dissolved with 80ml acetonitrile and refluxed at 80 ℃ for 36 h. After cooling to room temperature, acetonitrile was removed by distillation under the reduced pressure, and the residue was taken up with CH2Cl2Extraction (80mL) was performed 3 times and washing with saturated NaCl solution (80mL) was performed 3 times. The organic phases were combined, dried over anhydrous magnesium sulfate, filtered, concentrated, and subjected to silica gel column chromatography with a flowability of PE (petroleum ether): EA (ethyl acetate): 1:2 to obtain 2.5g of a white solid with a yield of 35.3%.
1H NMR(400MHz,Chloroform-d)δ9.79(s,1H),7.76(d,J=8.5Hz,2H),6.95(d,J=8.5Hz,2H),4.17–4.04(m,2H),4.04–3.88(m,2H),3.32(s,1H)。
13C NMR(101MHz,CDCl3)δ191.55,163.96,132.08,129.89,114.83,69.19,61.01。
(2) Synthesis of Compound 3: under the protection of nitrogen, 2(2.5g, 15.06mmol) and 2, 4-dimethylpyrrole (3g, 31.63mmol) were added into a 500mL two-necked flask, dissolved in 160mL of tetrahydrofuran, stirred for 30min, added with 160. mu.L of trifluoroacetic acid, and the reaction solution was stirred overnight with the color changed from yellow to red. After completion, a solution of DDQ (3.74g, 16.57mmol) in tetrahydrofuran was slowly added dropwise and after 3h, a solution of triethylamine (60mL) was added. Stirring is continued for 2h, and BF is added dropwise3·Et2O (60 mL). After stirring for 6 hours, most of the solvent was distilled off under reduced pressure, and then dissolved in 150mL of dichloromethane, washed with dilute hydrochloric acid 2 times, washed with saturated sodium bicarbonate solution twice, washed with saturated sodium chloride solution twice, dried over anhydrous magnesium sulfate, concentrated, and separated by silica gel column chromatography, and the mobile phase PE: EA 2:1 gave 1.25g of a dark red solid with a yield of 22%.
1H NMR(400MHz,Chloroform-d)δ7.09(d,J=8.4Hz,2H),6.88(d,J=8.5Hz,2H),5.73(s,2H),4.52(d,J=1.1Hz,1H),4.11–4.06(m,2H),4.00–3.94(m,2H),2.18(s,6H),1.85(s,6H)。
13C NMR(101MHz,CDCl3)δ157.03,135.05,129.69,126.48,125.54,114.43,108.65,69.06,61.40,39.43,12.77,11.16。
(3) Synthesis of Compound KS-23: compound 3(102.2mg, 0.2660mmol) and TAC-CHO (160mg, 0.2216mmol) were added to a 25mL round bottom flask, dissolved in 5mL ethanol, followed by 100. mu.L piperidine at reflux for 24 h. After completion, the reaction mixture was cooled to room temperature, the ethanol was removed by distillation under the reduced pressure, the mixture was dissolved in 20mL of dichloromethane, the mixture was washed three times with saturated brine (3X 40mL), the organic phases were combined, dried over anhydrous magnesium sulfate, concentrated, and separated by silica gel column chromatography with the flowability of DCM: MeOH: 75:1 to give 55mg of a dark blue solid with the yield of 23%.
1H NMR(400MHz,Chloroform-d)δ7.53(d,J=15.9Hz,1H),7.26–7.01(m,8H),6.89(d,J=8.0Hz,2H),6.67(d,J=8.3Hz,2H),6.61(s,2H),4.34–4.21(m,2H),4.18(t,J=4.4Hz,2H),4.06(q,J=4.7Hz,8H),3.89–3.83(m,2H),3.70(dq,J=29.1,8.4,7.2Hz,16H),3.56–3.42(m,7H),3.40–3.27(m,4H),2.60(s,3H),2.28(d,J=21.7Hz,6H),1.28(s,9H)。
Mass Spectrum (HRMS): c61H77O10N5BF2Calculating the value: 1088.57261, theoretical value: 1088.57690.
synthesis example 2
This synthesis example provides a method for synthesizing a reference probe RP, which specifically comprises:
(1) synthesis of Compound 5
Compound 4(5g, 25.2mmol), 2-aminoethanol (15.4g, 252mmol) and 80ml of ethanol were refluxed in a 150ml round-bottomed flask for 10 hours and then cooled. Filtering out precipitated solid and recrystallizing with ethanol to obtain pure product. Yield: 88.5 percent.
(2) Synthesis of RP
Compound 5(1.50g, 5mmol), Et3N (1.01g, 10mmol) and 80mL CH2Cl2After mixing, the mixture was cooled in an ice bath. Methacryloyl chloride (1.04g, 10mmol) was then added. After 6 hours at room temperature, concentrate in vacuo. Purifying the rest solid with silica gel column, and using petroleum ether/ethyl acetate (5:1) as developing agent to obtain pure solid. The yield was 89%.
1H NMR(400MHz,Chloroform-d)δ8.63(dd,J=7.3,1.1Hz,2H),8.25(dd,J=8.3,1.1Hz,2H),7.78(dd,J=8.2,7.3Hz,2H),6.07(dt,J=1.8,1.0Hz,1H),5.53(p,J=1.6Hz,1H),4.59(ddd,J=6.0,5.1,1.1Hz,2H),4.52(ddd,J=6.0,5.0,1.1Hz,2H),1.89(t,J=1.3Hz,3H)。
The NMR instrument used for characterization of the synthesis examples was Bruker Avance III and the Mass Spectrometer was Thermo LTQ Orbitrap XL Mass Spectrometer.
Example 1
The embodiment provides a potassium ion and dissolved oxygen dual-functional sensing film, and the preparation method thereof is as follows:
(1') mixing polyethylene glycol methacrylate, methacrylic acid, polyethylene glycol dimethacrylate, an oxygen probe, a reference probe, an initiator and a solvent, wherein the mass ratio of the polyethylene glycol methacrylate, the polyethylene glycol dimethacrylate, the oxygen probe, the reference probe, the initiator and the solvent is 800:50:5:5:10:1000, placing 30 microliter of mixed solution on a TMSPA modified quartz carrier, covering the quartz carrier with a cover glass, and placing the quartz carrier in an 80-DEG oven for polymerization for 1 hour. Taking out the glass cover, and removing the glass cover to obtain a film covered with a gel layer;
(2 ') the film obtained in step (1') was placed in 1mL of DMF solution containing 0.2mg of KS-23, 100mg of EDC and 20mg of DMAP to conduct grafting of a potassium ion probe. The reaction was carried out at room temperature after 12 hours. And taking out the film, washing the film by using DMF (dimethyl formamide) and deionized water to obtain the potassium ion and dissolved oxygen dual-functional sensing film, and performing performance test.
The method for preparing the potassium ion and dissolved oxygen dual-functional sensing film in example 1 is shown in fig. 1.
Test example 1
The potassium ion and dissolved oxygen dual-function sensing film (referred to as film for short) of example 1 was placed in a quartz watch glass, and 3ml of water was added. The concentration of oxygen is controlled by introducing mixed gas of nitrogen and oxygen with different oxygen partial pressures into the liquid. The concentration of potassium ions was controlled by adding varying concentrations of KCl to the liquid. The quartz dishes were tested in a PerkinElemer LS55 fluorescence tester (PerkinElemer, Waltham, MA, USA).
FIGS. 2a and 2b show the response of the reference probe to oxygen and potassium ions in the film, respectively, at an excitation wavelength of 350 nm. Since the probe does not contain groups responsive to potassium ions and oxygen, it can be clearly seen that the reference probe does not respond to both potassium ions and oxygen, demonstrating that the probe is a good reference.
FIG. 3a shows the response of the film to potassium ions under excitation at 405 nm, the concentration gradient of potassium ions is 0mM, 20mM, 40mM, 60mM, 80mM, 100mM, 120mM, 150mM, 200mM, 300mM, and it can be seen that the fluorescence at 574 nm increases with the increase of potassium ion concentration, while the fluorescence intensity from the oxygen probe at 670nm is not affected by the potassium ion concentration. FIG. 3b shows the response of the film to oxygen under 405 nm excitation, and it can be seen that the potassium probe does not respond to oxygen. Only the peak at 670nm of the oxygen probe increases as the concentration of oxygen decreases. Thus, a three-color bifunctional probe film is realized.
FIG. 4a shows the oxygen concentration and the fluorescence ratio (F) of the reference probe to the oxygen probe380/F670) FIG. 4b shows the potassium ion concentration and the fluorescence ratio of potassium ion probe to reference probe (F)574/F380) Wherein the fluorescence intensity of 380nm is used for the fluorescence of the reference probe, the fluorescence intensity of 670nm is used for the fluorescence of the oxygen probe, and the fluorescence intensity of 574 nm is used for the fluorescence of the potassium ion probe.
From FIG. 4a, it can be seen that the oxygen concentration (controlled by a 21-1-15-0-500-KMG3 model mass flow controller (Alicat Scientific, Tucson, AZ, USA)) and fluorescence intensity ratio obeyed the Stern-Volmer linear equation, indicating that oxygen concentration from anoxic (0mg/L) to saturated oxygen (oxygen solubility 8.6mg/L at normal atmospheric pressure with 21% oxygen in water at 23 degrees Celsius and saturated oxygen solubility 40.9mg/L at 100% oxygen partial pressure) can be measured well. Wherein the oxygen concentration refers to the concentration of dissolved oxygen.
From FIG. 4b, it can be seen that the probe can detect potassium ions from potassium ion-free solution to 100mM potassium solution with higher sensitivity, and the fluorescence intensity in this range is more sensitive to the change of the potassium ion concentration. Although the sensitivity decreased above 100mM, detection was still possible. Therefore, the material can realize the detection of potassium ion-free solution to solution containing 250mM potassium ions. Can be applied to the detection of potassium ions in blood (generally 3.5-5.5mM), can also realize the detection of potassium ions in urine (generally 25-125mM), and has certain application prospect.
Test example 2
A quartz plate (size 12.7X 1mm) with the sensor film of example 1 was placed diagonally in a 10X 10mm cuvette. Incident light was directed at an angle of 45 degrees to the quartz plate, 3mL of a buffer solution (Tris-HCl) having a pH of 7.4 was added to the cuvette, and then a 3M KCl solution was gradually added dropwise to increase the concentration from 0 to 300mM, and each titration was waited for 1min, and then data was collected.
FIG. 5a shows a graph comparing the effect of the film on the concentration of potassium and sodium ions on the fluorescence intensity (F)0Is the fluorescence intensity before no ions are added, F is the fluorescence intensity at different ion concentrations), figure 5b gives a graph comparing the fluorescence intensity of potassium ions with different physiologically relevant ions. It can be seen that sodium ions and other ions hardly affect the fluorescence of the film. Indicating that the sensing film has high selectivity to potassium ions.
(2) The oxygen and potassium ion concentrations in an aqueous solution containing about 150mM potassium ions were measured using 2 films (all obtained by the method of example 1), and the measured data were compared with the values obtained by electrode measurement, as shown in Table 1, and an error of less than 10% was found, indicating that there is a certain application prospect.
TABLE 1
The applicant states that the present invention is illustrated by the above examples to show the detailed process equipment and process flow of the present invention, but the present invention is not limited to the above detailed process equipment and process flow, i.e. it does not mean that the present invention must rely on the above detailed process equipment and process flow to be implemented. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
Claims (30)
1. The potassium ion and dissolved oxygen dual-function sensing film is characterized by comprising a carrier, and a potassium ion probe, an oxygen probe and a reference probe which are fixed on the surface of the carrier in a chemical bonding mode;
the potassium ion probe has the following structure:
the oxygen probe has the following structure:
the reference probe has the following structure:
3. a method for preparing the potassium ion and dissolved oxygen dual-function sensing film according to claim 1 or 2, wherein the method comprises the following steps:
(1') polymerizing polyethylene glycol methacrylate, methacrylic acid, polyethylene glycol dimethacrylate, an oxygen probe and a reference probe on the surface of a carrier to obtain the carrier covered with a hydrogel layer;
(2') grafting a potassium ion probe on the surface of the carrier covered with the hydrogel layer to obtain the potassium ion and dissolved oxygen dual-function sensing film.
4. The method according to claim 3, wherein the surface of the carrier contains a double bond.
5. The process according to claim 3, wherein in the step (1'), the initiator for the polymerization reaction is azobisisobutyronitrile.
6. The method according to claim 3, wherein in the step (1'), the solvent for the polymerization reaction is N, N-dimethylformamide.
7. The method according to claim 3, wherein in the step (1'), the support is a TMSPA-modified quartz support.
8. The method according to claim 3, wherein in the step (1'), the mass ratio of the polyethylene glycol methacrylate, the polyethylene glycol dimethacrylate, the oxygen probe, the reference probe, the initiator and the solvent is 500-1500:20-300:1-15:1-15:5-30: 1000.
9. The method according to claim 8, wherein in the step (1'), the mass ratio of the polyethylene glycol methacrylate, the polyethylene glycol dimethacrylate, the oxygen probe, the reference probe, the initiator and the solvent is 800:50:5:5:10: 1000.
10. The production method according to claim 3, wherein in the step (1'), the mass ratio of the methacrylic acid to the polyethylene glycol methacrylate is 10-1000: 1.
11. The method as claimed in claim 3, wherein the number average molecular weight of the polyethylene glycol methacrylate in step (1') is 300-2000.
12. The production method according to claim 11, wherein in the step (1'), the number average molecular weight of the polyethylene glycol methacrylate is 500.
13. The preparation method as claimed in claim 3, wherein in the step (1'), the number average molecular weight of the polyethylene glycol dimethacrylate is 300-2000.
14. The method according to claim 13, wherein in the step (1'), the number average molecular weight of the polyethylene glycol dimethacrylate is 750.
15. The production method according to claim 3, wherein in the step (1'), the polymerization reaction is carried out under a nitrogen atmosphere.
16. The production method according to claim 3, wherein in the step (1'), the temperature of the polymerization reaction is 70 to 90 ℃.
17. The production method according to claim 16, wherein in the step (1'), the temperature of the polymerization reaction is 80 ℃.
18. The process according to claim 3, wherein in the step (1'), the polymerization reaction time is 0.8 to 1.5 hours.
19. The method according to claim 18, wherein in the step (1'), the polymerization reaction time is 1 hour.
20. The process according to claim 3, wherein step (1') comprises in particular: mixing polyethylene glycol methacrylate, methacrylic acid, polyethylene glycol dimethacrylate, an oxygen probe, a reference probe, an initiator and a solvent, taking the mixed solution to be arranged on the surface of a TMSPA modified quartz carrier, and polymerizing for 0.8-1.5h at the temperature of 70-90 ℃ to obtain the carrier covered with the hydrogel layer.
21. The process according to claim 3, wherein in the step (2'), a coupling agent and/or a catalyst is added.
22. The method of claim 21, wherein the coupling agent is 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride.
23. The method of claim 21, wherein the catalyst is 4-dimethylaminopyridine.
24. The production method according to claim 3, wherein in the step (2'), the mass ratio of the potassium ion probe, the coupling agent and the catalyst is 2:1000: 200.
25. The method according to claim 3, wherein in the step (2'), the reaction solvent for grafting is N, N-dimethylformamide.
26. The method according to claim 3, wherein in the step (2'), the reaction time for grafting is 10 to 15 hours.
27. The method according to claim 26, wherein in the step (2'), the reaction time for grafting is 12 hours.
28. The method according to claim 3, wherein in the step (2'), the reaction of grafting is carried out at room temperature.
29. The method according to claim 3, wherein the step (2') comprises the steps of: and (3) placing the carrier covered with the hydrogel layer in a mixed solution of a potassium ion probe, a coupling agent and a catalyst, and carrying out grafting reaction for 10-15h at room temperature to obtain the potassium ion and dissolved oxygen dual-function sensing film.
30. Use of the potassium ion and dissolved oxygen bifunctional sensing membrane of claim 1 or 2 for potassium ion detection and dissolved oxygen detection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910832447.8A CN110437268B (en) | 2019-09-04 | 2019-09-04 | Potassium ion probe and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910832447.8A CN110437268B (en) | 2019-09-04 | 2019-09-04 | Potassium ion probe and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110437268A CN110437268A (en) | 2019-11-12 |
CN110437268B true CN110437268B (en) | 2022-01-14 |
Family
ID=68439181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910832447.8A Active CN110437268B (en) | 2019-09-04 | 2019-09-04 | Potassium ion probe and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110437268B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115487316B (en) * | 2022-01-26 | 2024-06-07 | 浙江大学 | Potassium ion selective filter membrane/magnetic mesoporous nanocomposite, fluorescence/magnetic resonance dual-mode imaging probe and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012154693A (en) * | 2011-01-24 | 2012-08-16 | Takuya Terai | Potassium fluorescent probe |
CN105503712A (en) * | 2015-12-11 | 2016-04-20 | 中国农业大学 | Pyridine-ethylbenzene-ether oxime esterPyrene ethylbenzene oxime-ethers esters compound, and preparation method and application thereof |
CN106929008A (en) * | 2017-03-14 | 2017-07-07 | 南方科技大学 | Potassium ion fluorescent probe and preparation method and application thereof |
CN108333162A (en) * | 2018-02-07 | 2018-07-27 | 南方科技大学 | Fluorescent oxygen probe and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9181375B2 (en) * | 2011-02-14 | 2015-11-10 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University | Fluorescent potassium ion sensors |
-
2019
- 2019-09-04 CN CN201910832447.8A patent/CN110437268B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012154693A (en) * | 2011-01-24 | 2012-08-16 | Takuya Terai | Potassium fluorescent probe |
CN105503712A (en) * | 2015-12-11 | 2016-04-20 | 中国农业大学 | Pyridine-ethylbenzene-ether oxime esterPyrene ethylbenzene oxime-ethers esters compound, and preparation method and application thereof |
CN106929008A (en) * | 2017-03-14 | 2017-07-07 | 南方科技大学 | Potassium ion fluorescent probe and preparation method and application thereof |
CN108333162A (en) * | 2018-02-07 | 2018-07-27 | 南方科技大学 | Fluorescent oxygen probe and preparation method and application thereof |
Non-Patent Citations (5)
Title |
---|
"A Highly Selective Mitochondria-Targeting Fluorescent K+ Sensor";Kong X X. et al;《Angew. Chem. Int. Ed》;20150821;第54卷;第12054页、摘要、第12056页左栏末段及supporting information第2页 * |
"Platinum porphyrin/3-(trimethoxysily)propyl methacrylate functionalized flexible PDMS micropillar arrays as optical oxygen sensors";Mao Y Y. et al;《New J. Chem》;20171231;第41卷;第5429-5435页 * |
Kong X X. et al."A Highly Selective Mitochondria-Targeting Fluorescent K+ Sensor".《Angew. Chem. Int. Ed》.2015,第54卷第12054页、摘要、第12056页左栏末段及supporting information第2页. * |
分子荧光探针在含能材料废水检测中的应用;张琦等;《现代化工》;20141120(第11期);第163-167页 * |
薄膜基荧光传感检测的研究进展;刘璐璐等;《中国科学:化学》;20200120(第01期);第39-69页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110437268A (en) | 2019-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11649311B2 (en) | Temperature-sensitive fluorescent probe for introduction into cell | |
CN110143966B (en) | Spiropyran-naphthalimide derivative and synthesis method and application thereof | |
CN108117544A (en) | A kind of reversible sulfur dioxide/sulfurous acid(Hydrogen)The fluorescence probe of salt | |
CN110698454B (en) | Isophorone hydrogen sulfide fluorescent probe and preparation method and application thereof | |
KR102513508B1 (en) | FLUOROGENIC pH-SENSITIVE DYES, FILM AND KIT COMPRISING THE SAME | |
CN104854152A (en) | Polymers having orthogonal reactive groups and uses thereof | |
CN103382189B (en) | One class cyanine compound, its preparation method and application | |
CN110437268B (en) | Potassium ion probe and preparation method and application thereof | |
CN114805262A (en) | Viscosity and polarity response type platform fluorescent probe, hydrogen sulfide detection fluorescent probe, synthesis process and application thereof | |
CN109180716B (en) | Multi-signal ratio type distinguishing detection H2O2And H2Design, synthesis and application of fluorescent probe of S | |
Liu et al. | Tricolor dual sensor for ratiometrically analyzing potassium ions and dissolved oxygen | |
CN105622540A (en) | CO probe and preparation method and application thereof | |
CN115772096B (en) | Two-photon fluorescent probe for double-channel detection and preparation method and application thereof | |
JP2015218304A (en) | Ratio-type fluorescent probe for intracellular temperature measurement | |
CN110357896A (en) | A kind of compound and preparation and its application in detection bivalent cupric ion and strong acid pH | |
CN110642976B (en) | Polymer potassium ion fluorescent probe and preparation method and application thereof | |
CN113999159B (en) | Viscosity-sensitive fluorescent probe, and preparation method and application thereof | |
CN111138639B (en) | pH response type conjugated polymer nano particle and preparation method and application thereof | |
CN112079822A (en) | Application of coumarin-cyanopyridine derivative in ratio detection of sulfur dioxide | |
CN110862405A (en) | Real-time detection of intracellular NADH/NAD+Fluorescent probe material, preparation method and application thereof | |
CN114507204B (en) | Golgi apparatus targeted superoxide anion fluorescent probe, preparation method and application thereof | |
CN118290462A (en) | Dual-channel simultaneous detection pH and ONOO-Fluorescent probe of (2), preparation method and application thereof | |
CN112409330B (en) | Novel Hg detection method 2+ The preparation method of the fluorescent molecular probe and the application thereof in the environment and the organism | |
CN109134483A (en) | A kind of hydrogen sulfide fluorescence probe and its preparation method and application | |
CN114853743B (en) | Cytosine-based cyanine probe and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |